Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology
Authors:
- Jonathan H. KimJKJonathan H. Kim
- Aaron L. BaggishABAaron L. Baggish
- Benjamin D. LevineBLBenjamin D. Levine
- Michael J. AckermanMAMichael J. Ackerman
- Sharlene M. DaySDSharlene M. Day
- Elizabeth H. DineenEDElizabeth H. Dineen
- J. Sawalla GusehJGJ. Sawalla Guseh
- Andre La GercheAGAndre La Gerche
- Rachel LampertRLRachel Lampert
- Matthew W. MartinezMMMatthew W. Martinez
- Michael PapadakisMPMichael Papadakis
- Dermot M. PhelanDPDermot M. Phelan
Top Cited Papers
- 18 March 2025
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 151 (11)
Abstract
Collaborators: Larry A. Allen, MD, MHS, FAHA, FACC; Mats Börjesson, MD, PhD, FACC; Alan C. Braverman, MD, FACC; Julie A. Brothers, MD; Silvia Castelletti, MD, MSc, FESC; Eugene H. Chung, MD, MPH, FHRS, FAHA, FACC; Timothy W. Churchill, MD, FACC; Guido Claessen, MD, PhD; Flavio D’Ascenzi, MD, PhD; Douglas Darden, MD; Peter N. Dean, MD, FACC; Neal W. Dickert, MD, PhD, FACC; Jonathan A. Drezner, MD; Katherine E. Economy, MD, MPH; Thijs M.H. Eijsvogels, PhD; Michael S. Emery, MD, MS, FACC; Susan P. Etheridge, MD, FHRS, FAHA, FACC; Sabiha Gati, BSc (Hons), MBBS, PhD, MRCP, FESC; Belinda Gray, BSc (Med), MBBS, PhD; Martin Halle, MD; Kimberly G. Harmon, MD; Jeffrey J. Hsu, MD, PhD, FAHA, FACC; Richard J. Kovacs, MD, FAHA, MACC; Sheela Krishnan, MD, FACC; Mark S. Link, MD, FHRS, FAHA, FACC; Martin Maron, MD; Silvana Molossi, MD, PhD, FACC; Antonio Pelliccia, MD; Jack C. Salerno, MD, FACC, FHRS; Ankit B. Shah, MD, MPH, FACC; Sanjay Sharma, BSc (Hons), MBChB, MRCP (UK), MD; Tamanna K. Singh, MD, FACC; Katie M. Stewart, NP, MS; Paul D. Thompson, MD, FAHA, FACC; Meagan M. Wasfy, MD, MPH, FACC; Matthias Wilhelm, MD This American Heart Association/American College of Cardiology scientific statement on clinical considerations for competitive sports participation for athletes with cardiovascular abnormalities or diseases is organized into 11 distinct sections focused on sports-specific topics or disease processes that are relevant when considering the potential risks of adverse cardiovascular events, including sudden cardiac arrest, during competitive sports participation. Task forces comprising international experts in sports cardiology and the respective topics covered were assigned to each section and prepared specific clinical considerations tables for practitioners to reference. Comprehensive literature review and an emphasis on shared decision-making were integral in the writing of all clinical considerations presented.Keywords
This publication has 262 references indexed in Scilit:
- Development of a Definition of Postacute Sequelae of SARS-CoV-2 InfectionJAMA, 2023
- Echocardiographic Characterization of Female Professional Basketball Players in the USJAMA Cardiology, 2020
- Association of Ascending Aortic Dilatation and Long-term Endurance Exercise Among Older Masters-Level AthletesJAMA Cardiology, 2020
- Weight Gain, Hypertension, and the Emergence of a Maladaptive Cardiovascular Phenotype Among US Football PlayersJAMA Cardiology, 2019
- Association of All-Cause and Cardiovascular Mortality With High Levels of Physical Activity and Concurrent Coronary Artery CalcificationJAMA Cardiology, 2019
- The Physical Activity Guidelines for AmericansJAMA, 2018
- Electrocardiographic Findings in National Basketball Association AthletesJAMA Cardiology, 2018
- Athletic Cardiac Remodeling in US Professional Basketball PlayersJAMA Cardiology, 2016
- Association of Fibrosis With Mortality and Sudden Cardiac Death in Patients With Nonischemic Dilated CardiomyopathyJAMA, 2013
- Competitive Sports Participation in Athletes With Congenital Long QT SyndromeJAMA, 2012